CERRA, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 948
EU - Europa 571
AS - Asia 347
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 1.872
Nazione #
US - Stati Uniti d'America 943
IT - Italia 202
IE - Irlanda 185
SG - Singapore 177
HK - Hong Kong 64
CN - Cina 53
RU - Federazione Russa 28
VN - Vietnam 27
GB - Regno Unito 25
FR - Francia 19
DE - Germania 18
FI - Finlandia 18
UA - Ucraina 13
KR - Corea 9
RO - Romania 9
SE - Svezia 9
BE - Belgio 8
CZ - Repubblica Ceca 7
ES - Italia 7
NL - Olanda 7
CH - Svizzera 5
IN - India 4
JP - Giappone 4
AT - Austria 3
MX - Messico 3
PL - Polonia 3
TW - Taiwan 3
CA - Canada 2
EU - Europa 2
LB - Libano 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
EG - Egitto 1
GR - Grecia 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.872
Città #
Chandler 220
Dublin 185
Singapore 145
San Mateo 101
Hong Kong 64
Perugia 64
Boardman 63
Santa Clara 53
Medford 37
Princeton 36
Altamura 32
Ann Arbor 31
Dong Ket 27
Redmond 26
Lawrence 25
Wilmington 22
Andover 15
Beijing 15
Des Moines 12
Los Angeles 12
Leeds 11
Saint Petersburg 11
Ashburn 10
Dearborn 10
Saronno 10
Bucharest 9
Seoul 9
Brussels 8
Norwalk 7
Arroyo de la Encomienda 6
Bologna 5
Falls Church 5
Redwood City 5
Dallas 4
Macerata 4
Munich 4
New York 4
Olomouc 4
Rome 4
Brno 3
Cambridge 3
Fremont 3
Helsinki 3
Jacksonville 3
Pune 3
San Paolo di Civitate 3
Torino 3
Woodbridge 3
Battipaglia 2
Clifton 2
Florence 2
Foligno 2
Fort Worth 2
Guangzhou 2
Houston 2
Kaohsiung 2
London 2
Menlo Park 2
Milan 2
Podlasie 2
San Giustino 2
San Jose 2
Sanremo 2
Scarborough 2
Southampton 2
Spoleto 2
Tokyo 2
Aguascalientes 1
Almaty 1
Bellagio 1
Belo Horizonte 1
Boydton 1
Buenos Aires 1
Cairo 1
Changsha 1
Chicago 1
Ciampino 1
Clearwater 1
Den Haag 1
Esslingen am Neckar 1
Fairfield 1
Frankfurt am Main 1
Groningen 1
Hanover 1
Jesi 1
Kiev 1
Kraków 1
La Canada Flintridge 1
Lappeenranta 1
Lausanne 1
Linyi 1
Ljubljana 1
Madrid 1
Melbourne 1
Montauk 1
Monza 1
Moscow 1
New Haven 1
Nishinomiya 1
Osaka 1
Totale 1.413
Nome #
Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist 106
Selected cholesterol biosynthesis inhibitors produce accumulation of the intermediate FF-MAS that targets nucleus and activates LXRα in HepG2 cells 96
9. The Systems Biology of Transporters – Targeting the Regulatory System for Transporters (FXR/RXR) 69
Selective continuous flow synthesis of hydroxy lactones from alkenoic acids 66
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor 63
Continuous Flow Synthesis and Enzymatic Resolution of 3-Hydroxy-ɣ-Butyrolactone (3-BHL): A Key Building Block for Synthesis and Drugs 62
A streamlined synthesis of the neurosteroid 3β-methoxypregnenolone assisted by a statistical experimental design and automation 62
Development of a Continuous Flow Synthesis of 16-Dehydropregnenolone Acetate: A Powered Entry into Steroids from Plants 59
Integrating Multicomponent Flow Synthesis and Computational Approaches for the Generation of a Tetrahydroquinoline Compound Based Library 58
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor: Molecular Determinants for Bile Acid Binding and Receptor Modulation 57
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands 57
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 57
Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists 55
The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology 54
ATYPICAL BILE ACIDS AS CHEMICAL PROBES FOR DIAGNOSIS AND THERAPHY MONITORING OF PROGRESSIVE CHOLESTATIC LIVER DISEASE IN HSD3B7 PATIENTS 49
Flow Nanoprecipitation of Size-Controlled D-Leucine Nanoparticles as Excipient for Spray-Drying Formulations 49
Mesofluidic Flash Nanoprecipitation of D-Leucine Particles as Excipient in Powders for Inhalation 49
The Stone Guest: How Does pH Affect Binding Properties of PD-1/PD-L1 Inhibitors? 49
Application of Untargeted and Targeted Metabolomics to the Study of Liver Disease Caused by a Deficiency in HSD3B7-diagnosis and Response to Therapy 48
Flow nanoprecipitation of size-controlled d-leucine nanoparticles for spray-drying formulations 48
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 48
Concepts and Optimization Strategies of Experimental Design in Continuous-Flow Processing 47
Synthesis of hydroxy lactones by selenium-mediated oxidation/cyclization of alkenoic acids under eco-flow conditions 45
Domino synthesis of 5-aminoimidazoles from Strecker multicomponent adducts via ytterbium-promoted isocyanide insertion/5-exo-dig cyclization 44
Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification 43
Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives 43
Continuous Flow Synthesis of 16-Dehydropregnenolone Acetate, a Key Synthon for Natural Steroids and Drugs 41
Identification and quantification of oxo-bile acids in human faeces with liquid chromatography–mass spectrometry: A potent tool for human gut acidic sterolbiome studies 40
Future medicinal chemists experience flow chemistry: optimization by experimental design of the limiting synthetic step to the antifungal drug econazole nitrate 34
First total synthesis of piperenol B and configuration revision of the enantiomers piperenol B and uvarirufol A 33
IDENTIFICATION OF A NOVEL CLASS OF PREGNANE X RECEPTOR (PXR) LIGANDS: FLOW SYNTHESIS AND PRELIMINARY BIOLOGICAL ACTIVITY OF TETRAHYDROQUINOLINES 31
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency 30
Synthesis of atypical bile acids for use as investigative tools for the genetic defect of 3b-hydroxy-Δ5-C27-steroid oxidoreductase deficiency 27
Speeding up Early Phases of Drug Discovery: DoE-Driven Synthetic Optimization of Chemical Processes in Flow Systems 27
Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms 27
Synthesis of 3beta,7alpha-Dihydroxy-Δ5-cholenoic Acid Derivatives: ‘Atypical’ Bile Acid Metabolites and Useful Biomarkers to Detect 3delta-HSDH Deficiency 26
Development of 3α, 7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-sulfate sodium salt (INT-767): Process optimization, synthesis and characterization of metabolites 24
Combining molecular modeling approaches to establish the chromatographic enantiomer elution order in the absence of pure enantiomeric standards: A study case with two tetracyclic quinolines 24
Merging Continuous Flow Technology, Photochemistry and Biocatalysis to Streamline Steroid Synthesis 23
Integrated Systems for Continuous Synthesis and Biological Screenings 22
Multicomponent and Metal-Free Diels–Alder/Aromatization Approach to the Stereospecific Synthesis of E-(Hetero)Stilbenes and Diarylacetylenes 21
Optimisation by design of experiment of benzimidazol-2-one synthesis under flow conditions 20
Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives 17
Isocyanide chemistry enabled by continuous flow technology 16
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C 16
Continuous Flow Synthesis of the PARP-1/2 Inhibitor HYDAMTIQ: Synthetic Strategy, Optimization, and Green Metrics Evaluation 15
Patented Farnesoid X receptor modulators: a review (2019 – present) 8
Totale 2.005
Categoria #
all - tutte 9.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 0 8 3 5 10 38 4 3
2020/2021142 3 0 2 2 69 4 21 2 7 3 1 28
2021/2022312 10 45 0 3 5 16 6 86 6 53 41 41
2022/2023650 39 109 6 84 52 62 0 28 238 10 18 4
2023/2024320 32 29 12 11 2 22 51 7 22 17 49 66
2024/2025310 19 69 25 39 127 31 0 0 0 0 0 0
Totale 2.005